New diabetes clinical trial: SAL067 Treatment in Patients With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise

Published on: March 23, 2023 at 11:00AM
Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: SAL067;   Drug: Alogliptin;   Drug: Placebo
Sponsor:   Shenzhen Salubris Pharmaceuticals Co., Ltd.
Completed
https://ift.tt/83CySmH